BioHarvest Sciences Secures $1.6 Million Grant from Israeli Innovation Authority

Reuters12-18
BioHarvest Sciences Secures $1.6 Million Grant from Israeli Innovation Authority

BioHarvest Sciences Inc., a biotechnology company specializing in its proprietary Botanical Synthesis™ platform, has been awarded a $1.6 million non-dilutive grant from the Israeli Innovation Authority (IIA). The funding, part of the IIA's Bio-Convergence program, will support the development of BioHarvest's second-generation Botanical Synthesis™ process. The grant will accelerate the integration of AI-based tools for process optimization, expand bioreactor capacity for improved production, and enhance autonomous manufacturing functions. The grant was awarded solely to BioHarvest Sciences Inc. and not to multiple organizations. Repayment is contingent on future revenues from the funded project, with no equity issued in connection with the grant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 278495) on December 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment